Filana Therapeutics (FLNA) Market Capitalization (2010 - 2026)

Filana Therapeutics has reported Market Capitalization for 17 years, with the latest figure at $57.5 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 34.25% year-over-year to $57.5 million in Q2 2026; TTM through Jun 2026 was $57.5 million, a 34.25% decrease from a year earlier, with the FY2025 full-year figure at $95.6 million, down 15.92% from the prior year.
• Market Capitalization was $57.5 million for Q2 2026 at Filana Therapeutics, down from $81.6 million in the prior quarter.
• The five-year high for Market Capitalization was $1.7 billion in Q3 2022, with the low at $57.5 million in Q2 2026.
• Average Market Capitalization over 5 years is $707.8 million, with a median of $789.3 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization surged 101.41% in 2024, then tumbled 91.74% in 2025.
• Over 5 years, Market Capitalization stood at $1.2 billion in 2022, then declined by 22.88% to $950.8 million in 2023, then sank by 88.03% to $113.8 million in 2024, then fell by 15.92% to $95.6 million in 2025, then slumped by 39.9% to $57.5 million in 2026.
• The last three Market Capitalization figures came in at $57.5 million (Q2 2026), $81.6 million (Q1 2026), and $95.6 million (Q4 2025), per Business Quant data.